fittingvalve

　　The Philips ultimate ultrasound solution for breast assessment is CE marked and has received 510(k) clearance from the U. According to a report published by the Journal of the US National Cancer Institute, an estimated 43.A patient-centric approach to breast examsMany clinicians depend on ultrasound to enhance detection of breast cancers, especially in women with dense breast tissue, which is unrelated to weight or breast size.PureWave eL18-4 ultra-broadband linear array transduceris a single transducer that Wholesale PPR ELBOW Suppliers delivers high-quality imaging for your patients, including those who may be more technically challenging to image.

　　“Ultrasound plays an increasingly important role in breast cancer screening and assessment, helping to detect lesions that mammography alone may not find. In combining both wave methods, ElastQ Imaging reveals more definitive information on tissue stiffness in the breast.With X-ray mammography, dense breast tissue can sometimes mask small cancerous lesions. “Our integrated ultrasound solution for breast assessment delivers high-quality imaging enhanced by anatomical intelligence for results clinicians can trust. With the new breast solution, clinicians can efficiently assess, monitor and treat breast diseases, increasing diagnostic confidence and helping to improve patient care.

　　First dedicated Philips ultrasound solution for breast assessment, combining advanced imaging, full solution elastography, screening and precision biopsyExceptional image quality combined with tailored breast exam tools gives clinicians more confidence to detect breast cancer and provide excellent patient careAmsterdam, the Netherlands–Royal Philips(NYSE: PHG, AEX: PHIA), a global leader in health technology, today announcedits ‘ultimate ultrasound solution for breast assessment. Clinicians often rely on ultrasound as a follow-up diagnostic test in cases where lesions are suspected.New precision biopsyallows physicians to enhance the patient experience by performing more targeted biopsies.